Sarah van Hellenberg Hubar-Fisher is the CEO of Bioretec and has a dynamic leadership background with over 21 years of strategic healthcare experience, particularly in HealthTech, MedTech, and Global Public Health. They have held key positions such as Managing Director at RePhil Capital BV and Global Public Health Strategic Finance Lead at Johnson & Johnson. Sarah has been recognized as an InspiringFifty TopFifty DeepTech leader in 2021 and was previously a Venture Partner at Growth Science Ventures and Nina Capital. Their academic credentials include an MBA in Entrepreneurship from Babson College and a Post Graduate Degree in Global Business from the University of Oxford.